Gastroparesis Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Gastroparesis Market  was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4% during 2021–2027.

Gastroparesis is a medical condition of the stomach that affects the normal voluntary movement of the stomach muscles. It limits normal digestion, causes vomiting, and causes problems with blood sugar levels and nutrition. Various drugs or drugs are prescribed to treat gastroparesis, such as reglan, erythromycin, and antiemetics. The increasing number of surgeries that cause gastroparesis after surgery, an increasing number of diabetic populations, an increasing elderly population, and the introduction of new drugs to control symptoms such as nausea and vomiting are driving the market.

Market Segments

By Drug Class

• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injections

By Disease Type

• Diabetic Gastroparesis
• Idiopathic Gastroparesis
• Post-surgical Gastroparesis
• Others

By End-User

• Hospitals
• Pharmacies
• Clinics
• E-commerce

Key Players

EVOKE PHARMA, Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., and Cinrx Pharma, LLC (Cindome Pharma) are among the key companies operating in the global gastroparesis market.

Scope of the Report

The research study analyzes the global Gastroparesis industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Gastroparesis Market Report

1. What was the Gastroparesis Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Gastroparesis Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Gastroparesis Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.